USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke BETTER MAB wurde als Wortmarke am 29.11.2011 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".
| Markenform | Wortmarke |
| Aktenzeichen | 85482864 |
| Anmeldedatum | 29. November 2011 |
| Veröffentlichungsdatum | 30. Oktober 2012 |
Markeninhaber
1872 Pratt Drive, Suite 1400
24060 Blacksburg
US
24060 Blacksburg
US
Markenvertreter
Waren und Dienstleistungen
1
Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting cellular activity or gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in modifying and regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; antibodies for scientific and research use; antibodies for regulating, modifying or regulating cellular functions in plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting cellular activity or gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
5
Chemical preparations for medical and veterinary purposes, namely, chemical preparations for regulating, modifying, or restricting cellular activity or gene expression for purposes of treating diseases and genetic disorders; chemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for antibody therapy analysis; Pharmaceutical preparations for modifying or regulating one or more cellular functions of mammals, fungi, plants, and bacteria and transgenic mammals, fungi, plants, and bacteria; transgenic plants, fungi and bacteria for medical and veterinary purposes; antibodies for use in disease testing; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
40
Custom manufacturing and custom synthesis of antibodies and genetically engineered DNA expressing antibodies, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
42
Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being antibodies and genetic therapies expressing antibodies to regulate, modulate, treat, prevent, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and antibody technology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells expressing antibodies for scientific, research, medical, veterinary and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Antibody technology and gene therapy services for others for product development and scientific research purposes, namely, antibody production, genetically engineering DNA expressing antibodies, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
44
Medical services; Medical services, namely, antibody and gene therapy services; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
45
Technology transfer services, namely, licensing and transfer of intellectual property; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1385482864